1. Home
  2. AMRK vs AMLX Comparison

AMRK vs AMLX Comparison

Compare AMRK & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRK
  • AMLX
  • Stock Information
  • Founded
  • AMRK 1965
  • AMLX 2014
  • Country
  • AMRK United States
  • AMLX United States
  • Employees
  • AMRK N/A
  • AMLX N/A
  • Industry
  • AMRK Other Specialty Stores
  • AMLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMRK Industrials
  • AMLX Health Care
  • Exchange
  • AMRK Nasdaq
  • AMLX Nasdaq
  • Market Cap
  • AMRK 524.3M
  • AMLX 459.1M
  • IPO Year
  • AMRK N/A
  • AMLX 2022
  • Fundamental
  • Price
  • AMRK $24.20
  • AMLX $7.68
  • Analyst Decision
  • AMRK Buy
  • AMLX Strong Buy
  • Analyst Count
  • AMRK 3
  • AMLX 8
  • Target Price
  • AMRK $33.00
  • AMLX $11.00
  • AVG Volume (30 Days)
  • AMRK 264.0K
  • AMLX 2.1M
  • Earning Date
  • AMRK 08-28-2025
  • AMLX 08-07-2025
  • Dividend Yield
  • AMRK 3.34%
  • AMLX N/A
  • EPS Growth
  • AMRK N/A
  • AMLX N/A
  • EPS
  • AMRK 1.57
  • AMLX N/A
  • Revenue
  • AMRK $10,991,521,000.00
  • AMLX N/A
  • Revenue This Year
  • AMRK $19.62
  • AMLX N/A
  • Revenue Next Year
  • AMRK $2.80
  • AMLX N/A
  • P/E Ratio
  • AMRK $15.24
  • AMLX N/A
  • Revenue Growth
  • AMRK 6.78
  • AMLX N/A
  • 52 Week Low
  • AMRK $19.39
  • AMLX $1.76
  • 52 Week High
  • AMRK $47.39
  • AMLX $7.72
  • Technical
  • Relative Strength Index (RSI)
  • AMRK 65.40
  • AMLX 75.73
  • Support Level
  • AMRK $21.91
  • AMLX $5.97
  • Resistance Level
  • AMRK $24.06
  • AMLX $6.86
  • Average True Range (ATR)
  • AMRK 0.79
  • AMLX 0.54
  • MACD
  • AMRK 0.25
  • AMLX 0.13
  • Stochastic Oscillator
  • AMRK 95.17
  • AMLX 98.29

About AMRK A-Mark Precious Metals Inc.

A-Mark Precious Metals Inc is a precious metal trading company. It is principally engaged in the wholesale of gold, silver, platinum, copper, and palladium bullion and related products in the form of bars, wafers, coins, and grains. The company's operating segment includes Wholesale Sales and Ancillary Services; Secured Lending and Direct-to-Consumer. It generates maximum revenue from the Wholesale Trading and Ancillary Services segment. The Wholesale Trading and Ancillary Services segment comprises business units such as Industrial, Coin and Bar, Trading and Finance, Storage, Logistics, and Mint. Geographically, it derives a majority of its revenue from the United States and the rest from Europe, Asia Pacific, Australia, Africa, and other regions.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: